Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Parsons

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Biochemistry|April 23, 1999
Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3J P Felix, R M Bugianesi, W A Schmalhofer, et al.
Transplantation|February 3, 1998
A tacrolimus-related immunosuppressant with reduced toxicityF J Dumont, S Koprak, M J Staruch, et al.
Transplantation|February 3, 1998
A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimusL B Peterson, J G Cryan, R Rosa, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicityH M Armstrong, F Wong, M A Holmes, et al.
Cellular Immunology|December 23, 1999
Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channelsG C Koo, J T Blake, K Shah, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Biochemistry|April 23, 1999
Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3J P Felix, R M Bugianesi, W A Schmalhofer, et al.
Transplantation|February 3, 1998
A tacrolimus-related immunosuppressant with reduced toxicityF J Dumont, S Koprak, M J Staruch, et al.
Transplantation|February 3, 1998
A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimusL B Peterson, J G Cryan, R Rosa, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicityH M Armstrong, F Wong, M A Holmes, et al.
Cellular Immunology|December 23, 1999
Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channelsG C Koo, J T Blake, K Shah, et al.
Pageof 3